BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2039825)

  • 1. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.
    Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ
    Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Arlin Z; Advani S; Allen SL; Goldman J; Snyder D; Foti A; Cline M
    J Clin Invest; 1991 Jun; 87(6):2042-7. PubMed ID: 2040694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential relapses of blastic crisis may involve different clones of cells with different molecular abnormalities.
    Foti A; Cline MJ
    Br J Haematol; 1994 Jul; 87(3):627-30. PubMed ID: 7993808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.
    Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
    Cline MJ; Jat PS; Foti A
    Leuk Lymphoma; 1992 Jul; 7(4):283-7. PubMed ID: 1493427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
    Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
    Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
    Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H
    Blood; 2000 Feb; 95(4):1144-50. PubMed ID: 10666183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double P53 point mutation in extramedullary blast crisis of chronic myelogenous leukemia.
    Marasca R; Longo G; Luppi M; Barozzi P; Torelli G
    Leuk Lymphoma; 1994 Dec; 16(1-2):171-5. PubMed ID: 7696924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation.
    Foti A; Bar-Eli M; Ahuja HG; Cline MJ
    Br J Haematol; 1990 Sep; 76(1):143-5. PubMed ID: 2223633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis.
    Guinn BA; Smith M; Padua RA; Burnett A; Mills K
    Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
    Kokate P; Dalvi R; Mandava S
    J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCR rearrangement and cytogenetic findings in Philadelphia-positive chronic myelocytic leukemia in children].
    Shikano T; Kikuta H; Ishikawa Y; Naito H; Ohkawa M; Nakadate N; Hatae Y; Takeda T
    Rinsho Ketsueki; 1989 Jan; 30(1):29-35. PubMed ID: 2716196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia.
    Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A
    Br J Haematol; 1995 Nov; 91(3):625-9. PubMed ID: 8555065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
    Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
    Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of M-bcr breakpoint with different chromosomal abnormalities in blast crisis Ph1-positive CML.
    Mills KI; Stewart J; Burnett AK
    Leuk Res; 1991; 15(11):999-1003. PubMed ID: 1961015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
    Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia.
    Schütte J; Opalka B; Becher R; Bardenheuer W; Szymanski S; Lux A; Seeber S
    Leuk Res; 1993 Jun; 17(6):533-9. PubMed ID: 8505851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.